INTECH Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11M Hold
124,172
0.01% 1135
2025
Q1
$931K Buy
124,172
+26,379
+27% +$198K 0.01% 1237
2024
Q4
$735K Buy
97,793
+43,556
+80% +$328K 0.01% 1335
2024
Q3
$412K Buy
+54,237
New +$412K ﹤0.01% 1332